TRIPLE NEGATIVE BREAST NEOPLASMS
Clinical trials for TRIPLE NEGATIVE BREAST NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new TRIPLE NEGATIVE BREAST NEOPLASMS trials appear
Sign up with your email to follow new studies for TRIPLE NEGATIVE BREAST NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can switching between two powerful drugs beat advanced breast cancer?
Disease control Not yet recruitingThis study tests whether alternating two different targeted drugs (sacituzumab govitecan and trastuzumab deruxtecan) helps people with advanced HER2-low triple-negative breast cancer live longer compared to using just one drug alone. About 260 adults with metastatic or locally ad…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 26, 2026 03:21 UTC
-
New hope for tough breast cancer: Two-Drug combo battle begins
Disease control Not yet recruitingThis study tests two different drug combinations as a first treatment for people with advanced triple-negative breast cancer that has spread and is PD-L1 positive. About 150 participants will be randomly assigned to receive either sacituzumab govitecan plus toripalimab or toripal…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 20, 2026 11:53 UTC